In a landmark decision that brings relief to thousands of medical aspirants, the Islamabad High Court (IHC) declared on Saturday that the Medical and Dental Colleges Admission Test (MDCAT) results of November 2022 were valid for two years as per the regulations in place at last year. The judgment issued by Justice Miangul Hasan Aurangzeb on a petition filed by one Laiba Rauf, means that the students who passed the MDCAT in November 2022 can now seek admission to medical colleges in 2024. Rauf had challenged the Pakistan Medical and Dental Council's (PMDC) public notice of July 14, 2023, which stated that MDCAT results from 2022 would not be valid for admissions in 2023, despite the regulations at that time clearly stating a two-year validity period. Read also: SHC issues notices against re-leak of MDCAT paper The court found that the PMDC's attempt to retract the two-year validity period through a subsequent administrative decision was illegal and violated the rights of students, who had appeared for the exam under the previous regulations. "This right cannot be withdrawn from the petitioner by a subsequent administrative decision," the court stated. Justice Aurangzeb further directed the PMDC to bear the expenses incurred by Rauf in pursuing the case.
from Pakistan News, Latest News Pakistan, Pakistan Headline | The Express Tribune https://ift.tt/r7vR0t8
Subscribe to:
Post Comments (Atom)
Meet the women leading key administrative roles in Sialkot
For the first time in its history, Sialkot district has become a trailblazer in gender inclusion within the provincial bureaucracy, now boas...
-
The Sindh High Court (SHC) heard a petition regarding the restoration of the students union in the University of Karachi and sought a respon...
-
Punjab’s Health Minister Dr Javed Akram underscores the significance of exercise and walking for both a healthy life and treatment of variou...
-
Fake Canadian visas were recovered from four passengers going to Saudi Arabia at Islamabad airport. FIA Immigration offloaded and transferre...
No comments:
Post a Comment